Compare Freeport-McMoRan Inc (FCX) vs Smith & Nephew plc (SNN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Freeport-McMoRan Inc vs Smith & Nephew plc — how do they compare? Freeport-McMoRan Inc trades at $69.5 (market cap $96.42B), while Smith & Nephew plc trades at $30.05 (market cap $12.54B). The key difference: Freeport-McMoRan Inc is far larger — about 7.7× Smith & Nephew plc's market cap, and Smith & Nephew plc pays the higher dividend (2.65%). Which is the better fit depends on your goals.
| FCX | SNN | |
|---|---|---|
Market Cap | $96.42B | $12.54B |
Sector | Basic Materials | Health |
52-Week High | $71.73 | $38.70 |
52-Week Low | $35.34 | $28.73 |
Enterprise Value | $102.70B | $15.57B |
Dividend Yield | 0.87% | 2.65% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Freeport-McMoRan Inc
Freeport-McMoRan Inc is an international mining company. It operates geographically diverse assets with proven and probable mineral reserves of copper, gold and molybdenum. The company's portfolio of assets includes the Grasberg minerals district in Indonesia
Read more on FCX →About Smith & Nephew plc
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →
